Atipamazole

19 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

530.0%

Death Rate

Active Ingredients

Atipamazole

Administration Routes

UnknownIntramuscularParenteral

Species Affected

Dog 18

Cat 1

Most Affected Breeds

Retriever - Labrador 3

Pit Bull 2

Dog (other) 1

Dog (unknown) 1

Shepherd Dog - German 1

Maltese 1

Hound (unspecified) 1

Bulldog - French 1

Bullmastiff 1

Mastiff (unspecified) 1

Most Reported Reactions

Vomiting 4

Sedation prolonged 3

Seizure NOS 3

Tachycardia 3

Injection site swelling 3

Lack of efficacy - NOS 3

Agitation 2

Vocalisation 2

Anorexia 2

Decreased appetite 2

Ataxia 2

Decreased urine concentration 2

Outcome Breakdown

Recovered/Normal

9 (47.4%)

Outcome Unknown

6 (31.6%)

Ongoing

3 (15.8%)

Died

1 (5.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.